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Medial nucleus tractus solitarius (mNTS) neurons
express leptin receptors (LepRs), and intra-mNTS
delivery of leptin reduces food intake and body
weight. Here, the contribution of endogenous LepR
signaling in mNTS neurons to energy balance control
was examined. Knockdown of LepR in mNTS and
area postrema (AP) neurons of rats (LepRKD) via
adeno-associated virus short hairpin RNA-interfer-
ence (AAV-shRNAi) resulted in significant hyper-
phagia for chow, high-fat, and sucrose diets, yielding
increased body weight and adiposity. The chronic
hyperphagia of mNTS/AP LepRKD rats is likely medi-
ated by a reduction in leptin potentiation of gastroin-
testinal satiation signaling, as LepRKD rats showed
decreased sensitivity to the intake-reducing effects
of cholecystokinin. LepRKD rats showed increased
basal AMP-kinase activity in mNTS/AP micro-
punches, and pharmacological data suggest that
this increase provides a likely mechanism for their
chronic hyperphagia. Overall these findings demon-
strate that LepRs in mNTS and AP neurons are
required for normal energy balance control.
INTRODUCTION
Fifteen years after the discovery of leptin (Zhang et al., 1994), the
adipose tissue-derived hormone continues to influence thinking
about the nature of central nervous system (CNS) circuits that
control energy balance. Explanations for the potent decrease
in food intake and increase in energy expenditure triggered by
central leptin signaling focus almost exclusively on one region
of leptin receptor (LepR)-bearing nuclei, the arcuate (ARC) hypo-
thalamus (Barsh and Schwartz, 2002). Only recently has atten-
tion been directed toward evaluating contributions of other,
extra-ARC and extra-hypothalamic LepRs (Dhillon et al., 2006;
Fulton et al., 2006; Hommel et al., 2006; Myers et al., 2009).
Two recent reports are beginning to move the attention of theCfield away from the ARC-centric notion of leptin action by
showing that in the absence of LepR signaling in the neurons
of the hypothalamic ventromedial nucleus (VMN) or the midbrain
ventral tegmental area (VTA), rodents become hyperphagic
(Dhillon et al., 2006; Hommel et al., 2006). These data contribute
to a developing perspective that the energy balance effects of
leptin are anatomically distributed rather than centered in the
ARC (Grill and Hayes, 2009; Hommel et al., 2006; Huo et al.,
2007; Myers et al., 2009).
Behavioral analyses of meal patterns show that the intake-
reducing effects following leptin treatment occur by a reduction
in meal size, not by an alteration in meal number or frequency
(Eckel et al., 1998; Kahler et al., 1998). Interestingly, the same
meal pattern effect is produced by within-meal satiation signals
arising from the gastrointestinal (GI) tract (Moran, 2006; Rutti-
mann et al., 2009; West et al., 1984). The common meal size
suppressive effects of leptin and GI satiation signals suggest
that the intake-reducing effect of leptin may result from interac-
tionswith theCNSprocessing of GI satiation signals (e.g., gastric
distension, glucagon-like-peptide-1, and cholecystokinin [CCK])
(Huo et al., 2007; Matson et al., 2000; Schwartz and Moran,
2002; Williams et al., 2006). Data supporting the hypothesis
that neurons of the nucleus tractus solitarius (NTS) serve as
a site of leptin and GI satiation signal convergence show that:
(1) CNS leptin delivery amplifies the neurophysiologic response
of NTS neurons to gastric distension (Schwartz and Moran,
2002), (2) 39% of mNTS neurons are responsive to leptin and
gastric distension (Huo et al., 2007), and (3) a subthreshold
dose of hindbrain-delivered leptin amplifies the intake-reducing
effects of a subthreshold volume of gastric distention (Huo
et al., 2007). Collectively these findings indicate that mNTS
LepR signaling can reduce food intake by interacting with
GI-vagally transmitted satiation signals. Whether mNTS LepR-
expressing neurons are required for normal food intake control
and overall energy balance regulation is unknown.
It is likely that a common intracellular signaling pathway(s)
withinmNTS neurons accounts for the interaction between leptin
signaling and GI satiation signal processing. Examination of the
intracellular pathways that may mediate the intake-suppressive
effects of leptin action in the mNTS focus on the fuel-sensing
enzyme, adenosine monophosphate-activated protein kinaseell Metabolism 11, 77–83, January 6, 2010 ª2010 Elsevier Inc. 77
Figure 1. Leptin Receptor Knockdown in the mNTS and AP Increases Daily Caloric Intake
(A and B) Representative immunofluorescent analysis showing the extent of AAV-shCtrl (A) and AAV-LepR (B) spread, with EGFP-expressing neurons being
identified in nuclei that contain the LepR: mNTS and AP. EGFP-expressing neurons are also found in non-LepR-expressing nuclei: DMV, dorsolateral NTS
(SolDL), and solitary commissural (SolC). cc, central canal.
(C) Representative qPCR reveals significant suppression in LepR mRNA in mNTS/AP micropunched tissue for AAV-LepR-treated rats compared to AAV-shCtrl
rats. *p < 0.05.
(D) Daily Kcal intake for LepRKD and shCtrl rats pre- and postviral delivery while maintained on chow or high fat (HF) diet (60% Kcal from fat). * = p < 0.05 for
bracketed weekly averages.
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NTS LepR Requirement for Energy Balance Regulation(AMPK) (Hayes et al., 2009). The intake-reducing effects of hind-
brain leptin delivery were found to be mediated by AMPK, as
increased hindbrain AMPK activity by fourth intracerebroventric-
ular (i.c.v.) AICAR delivery reversed hindbrain leptin-induced
inhibition of food intake and AMPK activity in NTS-enriched
lysates. These findings highlight a role for mNTS AMPK activity
in energy balance control.
To assess the role of endogenous leptin signaling in mNTS
LepR-expressing neurons to the normal physiology of energy
balance control, we utilized RNAi-mediated LepR knockdown
(Hommel et al., 2006). Rats received bilateral mNTS-paren-
chymal injections of an adeno-associated virus (AAV2) engi-
neered to express either shRNA targeting LepR mRNA (AAV-
shLepR) or scrambled shRNA (AAV-shCtrl). The daily caloric
intake, energy expenditure parameters (core temperature and
physical activity), body weight gain, and white adipose tissue
(WAT) mass of rats maintained on chow or high-fat (HF) diet
were compared. To determine whether endogenous mNTS lep-
tin signaling contributes to the food intake-reducing effects of
GI satiation signals, responses to intraperitoneal (i.p.) CCK
were assessed. The effect of mNTS-directed AAV-shLepR on
basal hindbrain AMPK activity and the feeding effect of pharma-78 Cell Metabolism 11, 77–83, January 6, 2010 ª2010 Elsevier Inc.cological inhibition of hindbrain AMPK activity were also
examined.
RESULTS
Quantification of In Vivo LepR Knockdown
and Histological Confirmation of Viral Infection
Figures 1A and 1B illustrate representative histological confirma-
tion of AAV-shCtrl and AAV-shLepR infection of mNTS and AP
neurons by expression of enhanced green fluorescent protein
(EGFP; coexpressed by the AAV). In addition, adjacent non-
LepR-expressing nuclei of the dorsal motor nucleus of the vagus
(DMV), dorsolateral NTS, solitary commissural, and lateral NTS
were also infected by the AAV and express EGFP. However,
given that LepRs are expressed only in the mNTS and AP in
the infected region (Huo et al., 2007; Li et al., 1999), only RNA
extracted from cells from micropunches of AAV-infected
mNTS/AP tissue were analyzed by quantitative real-time poly-
merase chain reaction (qPCR). Representative qPCR analysis
revealed a 41% decrease in LepR mRNA in mNTS/AP neurons
infected with AAV-shLepR (n = 6), compared with neurons
infected with AAV-shCtrl (n = 12; Figure 1C).
Figure 2. Increased Body Weight Gain
Following Knockdown of mNTS/AP LepR
Cumulative body weight of chow-maintained
LepRKD and shCtrl rats pre- and post-mNTS/
AP-directed AAV delivery. *p < 0.05 for bracketed
weekly averages. (Inset) Graph shows inguinal
and total WAT mass for LepRKD and shCtrl rats.
*p < 0.05.
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Intake and Body Weight Gain
LepRKD rats maintained on standard chow showed a significant
increase in weekly averaged daily caloric intake during the
second and fifth week postviral delivery compared to shCtrl
rats (Figure 1D). When the diet was switched to HF diet at 5.5
weeks postviral delivery, weekly averaged daily caloric intake
was significantly greater in LepRKD rats than shCtrl rats for the
next 3 weeks.
LepRKD rats showed a significantly greater decrease in
average body weight compared to shCtrl rats in the first 9 days
following viral delivery, attributed to the weight loss seen within
the first 24 hr following viral injection. However, beginning
3.5 weeks postviral delivery, body weight for LepRKD rats was
significantly greater than that of shCtrl rats (Figure 2). This sig-
nificant increase in body weight gain for LepRKD rats continued
when rats were switched to HF diet for the remaining 3 weeks of
the experiment. Postmortem analysis of WAT depots (8.5 weeks
post-AAV delivery) revealed that the inguinal WAT mass was
significantly greater in LepRKD rats compared to shCtrl rats
(Figure 2, inset). There was no significant difference in retroper-
itoneal (19.7 ± 1.6 g versus 17.4 ± 1.4 g), epididymal (20.0 ± 1.9 g
versus 16.7 ± 1.4 g), or perirenal (6.6 ± 0.8 g versus 5.8 ± 0.8 g)
WAT depots between the LepRKD and shCtrl rats, respectively.
The increase in inguinal fat mass accounted for the majority of
the increase in total WAT mass for LepRKD rats compared to
shCtrl rats (Figure 2, inset).
Analysis of core body temperature and physical activity for
LepRKD and shCtrl rats showed no differences in either energy
expenditure parameter for either group following AAV delivery
compared to within-subject pre-AAV delivery baseline values
(see Figures S1 and S2 available online).
Endogenous LepR Signaling in mNTS/AP Neurons
Is Required for the Intake-Suppressive Effects of CCK
To test the hypothesis that the intake-suppressive effects of CNS
LepR signaling result from potentiation of the intake-inhibitory
effects of GI satiation signals within mNTS neurons, 15%Cell Metabolism 11, 77–8sucrose intake of LepRKD and shCtrl
rats was tested following i.p. injection of
the GI satiation signal CCK. Figure 3A
shows that for both groups, sucrose
intake following vehicle injection was
identical prior to viral delivery, as was
the intake-suppressive effect of CCK
(3 mg/kg). By contrast, 4 weeks following
viral delivery, clear differences in sucrose
intake were observed, with LepRKD rats
consuming significantly more sucroseunder vehicle-injection conditions compared to shCtrl rats
(Figure 3A). This significant increase in sucrose intake occurred
within 10 min of sucrose access (first meal) and persisted for
the 1 hr duration of testing. LepRKD rats showed reduced sensi-
tivity to the intake-suppressive effects of CCK (with no significant
inhibition of sucrose intake) compared to shCtrl rats that
continue to display a significant inhibition of sucrose intake
by CCK.
To determine whether baseline hyperphagia of sucrose and
reduced sensitivity to the intake-suppressive effects of CCK in
LepRKD rats were selective to a palatable test diet, the effects
of i.p. CCK (3 mg/kg) on maintenance chow was examined in
other rats. Six weeks postviral delivery, CCK-treated LepRKD
rats failed to significantly suppress 30 min chow intake, while
the same treatment significantly suppressed chow intake in
shCtrl rats (32.9% ± 22.7% versus 67.5% ± 19.5% suppression
compared to within-subject intakes following i.p. saline, re-
spectively).
Endogenous LepR Signaling in mNTS/AP Neurons
Controls for Food Intake by an AMPK-Dependent
Mechanism
The effect of mNTS-directed AAV-LepR on basal hindbrain
AMPK activity (ad libitum chow-fed rats) was evaluated through
immunoblot analysis of phosphorylation of AMPKa2 (pAMPKa2)
and total AMPKa levels in mNTS/AP tissue lysates compared to
pAMPKa2 levels in shCtrl rats 7 weeks post-AAV delivery.
Figure 3B shows significant elevations of basal pAMPKa2 in
LepRKD rats compared to shCtrl rats. Total AMPKa levels
were equivalent.
To determine whether elevated pAMPKa2 levels in mNTS/AP
of LepRKD rats contributes to their chronic hyperphagia, the
feeding effect of fourth i.c.v. compound C delivery was tested
in chow-maintained LepRKD and shCtrl rats 3 weeks postviral
delivery. Figure 3C shows that daily (24 hr) chow intake for
LepRKD rats was significantly greater than that of shCtrl rats
following fourth i.c.v. vehicle administration. CompoundC (15mg),
at a dose subthreshold for effect in shCtrl rats, significantly3, January 6, 2010 ª2010 Elsevier Inc. 79
Figure 3. Endogenous LepR Signaling in mNTS/AP Neurons Is Required for the Intake-Suppressive Effects of CCK and Controls for Food
Intake via an AMPK-Dependent Mechanism
(A) Cumulative 15% sucrose intake following i.p. injection of CCK (3 mg/kg) or vehicle (0.9% saline) for LepRKD and shCtrl rats pre- and 4 weeks post-mNTS-
directed AAV delivery. *p < 0.05.
(B) LepRKD rats showed increased pAMPKa2 levels in mNTS/AP micropunched tissue compared to shCtrl rats under ad libitum-fed conditions. Representative
immunoblots for total AMPK and pAMPKa2 are shown. Relative pAMPKa2 = the ratio of pAMPKa2 to total AMPK. *p < 0.05.
(C) Cumulative chow intake for LepRKD and shCtrl rats following fourth i.c.v. delivery of compound C (15mg) or vehicle (DMSO). *p < 0.05.
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the intake of shCtrl rats following vehicle administration. There
was a nonsignificant trend for inhibition of intake by compound
C in LepRKD rats at 6 hr postinjection (p = 0.11).
DISCUSSION
Endogenous CNS leptin signaling plays a pivotal role in energy
balance control (Bence et al., 2006; Cohen et al., 2001; Dhillon
et al., 2006; Hommel et al., 2006; Myers et al., 2009; Zhang
et al., 1994). Less is known, however, about which of the various
nuclei and possible mediating mechanisms are relevant to the
control of food intake by leptin. Here we show endogenous
NTS LepR signaling is required for food intake and body weight
control through a mechanism involving NTS LepR interactions
with GI satiation signaling and AMPK activity.
AAV-mediated knockdown of LepR restricted to the mNTS
and adjacent AP increased body weight gain compared to
controls. The increased body weight gain was characterized by
elevated fat mass and increased daily caloric intake, likely stem-
ming from reduced sensitivity to vagally mediated satiation
signaling and increased basal AMPK activity in the NTS. The
chronic hyperphagia by LepRKD rats was observed when rats
were maintained on either chow or HF diet, although the magni-80 Cell Metabolism 11, 77–83, January 6, 2010 ª2010 Elsevier Inc.tude of the caloric hyperphagia (and increase in body weight
gain) was greater with HF diet maintenance. The chronic hyper-
phagia was not associated with a compensatory increase in
either core temperature or physical activity.
An interaction between CNS LepR signaling and the neural
processing of GI satiation signals contributes to the intake inhib-
itory effects of leptin (Huo et al., 2007; Matson et al., 2000;
Schwartz and Moran, 2002; Williams et al., 2006). The mNTS
neurons are a primary site of this interaction. Current findings
provide critical support for this mNTS-based hypothesis,
showing that reduced mNTS/AP LepR signaling: (1) dramatically
decreased sensitivity to the intake reducing effects of i.p. CCK
administration (for both chow and 15% sucrose) and (2)
increased the size of the first sucrose meal (10 min postsucrose
presentation). The chronic hyperphagia by LepRKD rats was not
limited to palatable food (i.e., sucrose and HF diet) but extended
to chow diet. Other work from our laboratory shows that mNTS
LepR signaling also interacts with the processing of gastric
distension signals to control food intake (Huo et al., 2007).
Thus, it is likely that the hyperphagia followingmNTS/APLepRKD
results from a reduction in the potentiated signaling within mNTS
neurons between leptin and various GI satiation signals.
The finding that pAMPKa2 levels were elevated in mNTS/AP
micropunches of the LepRKD compared to shCtrl rats offers a
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and provides further support for the hypothesis that CNS AMPK
signaling plays a key role in mediating leptin’s effects on energy
balance (Hayes et al., 2009; Minokoshi et al., 2004). Recently,
hindbrain leptin administration was shown to reduce (1) AMPK
activity in NTS-enriched tissue; and (2) food intake, in part by
the suppression of AMPK activity (Hayes et al., 2009). Current
results show that mNTS/AP LepRKD increased basal pAMPKa2
levels (correlated with an elevation in AMPK activity [Hayes et al.,
2009; Minokoshi et al., 2004]) in mNTS/AP micropunches and
suggest that the increased basal phosphorylation of AMPK is
a consequence of chronically reduced LepR signaling. Elevated
AMPK activity may provide a mechanism for the hyperphagia
(Minokoshi et al., 2004) and for the decreased sensitivity to sati-
ation signals observed in the LepRKD rats. Indeed, inhibition of
hindbrain AMPK activity by fourth i.c.v. compound C reduced
daily caloric intake of LepRKD rats to a level comparable to
that of shCtrl rats. This dose of compound C had no intake effect
in shCtrl rats with lower basal AMPK activity in the mNTS/AP,
suggesting that LepRKD rats with higher basal AMPK activity
are more sensitive to local AMPK inhibition.
Together with the lack of effect on core temperature and phys-
ical activity for mNTS/AP LepRKD rats, the hyperthermia and
tachycardia effects observed following exogenous fourth i.c.v.
(Skibicka andGrill, 2009) or mNTS parenchyma (our unpublished
data) leptin injections suggest that NTS LepR signaling is suffi-
cient in acute stimulation conditions but may not be necessary
for the activity or thermic effects of endogenous LepR signaling.
This notion is consistent with the perspective that CNS leptin-
mediated control of energy expenditure is mediated by anatom-
ically distributed networks and involves functional redundancy
across other CNS LepR-expressing neurons.
Total adiposity of mNTS/AP LepRKD rats was greater than
that of shCtrl rats, with the inguinal WAT mass accounting for
the most significant change. Decreased NTS LepR-mediated
sympathetic nervous system (SNS) tone to the inguinal WAT
(Bamshad et al., 1998; Bowers et al., 2004) may explain the
increase observed following mNTS/AP LepR knockdown,
possibly through altered fat cell proliferation and/or decreased
lipolysis within this depot. This hypothesis is supported by find-
ings (Bowers et al., 2004; Foster and Bartness, 2006) showing
that denervation of inguinal WAT results in a significant increase
in fat cell mass and number. It also is possible that the increase in
inguinal WAT seen in LepRKD rats is secondary to their chronic
hyperphagia as a result of differential regulation of lipogenesis by
CNS leptin signaling (Buettner et al., 2008), which also involves
SNS mediation.
The qPCR results, histological confirmation of localized EGFP-
expression in mNTS and AP neurons, and absence of LepR-
expressing nuclei within the immediate vicinity of viral injections
within the caudal brain stem (Huo et al., 2007; Li et al., 1999) indi-
cate that the phenotype described results from reduction in
LepR signaling by LepRKD only in the mNTS and AP. The re-
combinant AAV2 capsids used only transduce in local neuronal
cell bodies and are not transported in a retro- or anterograde
fashion (Burger et al., 2004). Thus, it is fair to assume that knock-
down occurred only in LepR-expressing neurons of the mNTS
and AP and that no alteration of LepR expression on astrocytes
or glial cells of the NTS and AP (Dallaporta et al., 2009) occurred.CLikewise, there was no alteration in any other CNS or vagal
LepR-expressing nuclei that project to the NTS (Blevins et al.,
2004; Peters et al., 2005; Zheng et al., 2005).
Rats with LepRKD in the VTA (Hommel et al., 2006), and mice
with LepRKD restricted to VMN neurons (Dhillon et al., 2006), are
hyperphagic under certain conditions, supporting a role for
endogenous LepR signaling in food intake control in additional
brain regions. Thus far, however, there is no indication that an
alteration in satiation signal processing contributes to the hyper-
phagia of these models. In contrast, a case for a connection
between ARC LepR signaling and satiation signal processing
has been made (Morton et al., 2005). Those experiments show
that the hyperphagia that drives the obesity of Koletsky rats is
characterized by (1) an increase in meal size but not in meal
frequency and (2) reduced sensitivity to the intake inhibitory
effects of CCK. Together with current findings, the intake-inhib-
itory effects of endogenous CNS LepR signaling involve potenti-
ation of the intake-inhibitory effects of GI satiation signals in at
least two anatomically distributed nuclei, the ARC and mNTS.
Selective knockdown of LepR in mNTS and AP neurons signif-
icantly increased body weight gain and total adiposity and was
attributed to chronic hyperphagia of maintenance chow and
HF diet. This chronic hyperphagia was correlated with reduced
sensitivity to the intake-suppressive effects of CCK and a basal
increase in mNTS/AP AMPK activity. These data support the
perspective of an anatomically distributed control of energy
balance, whereby leptin signaling and AMPK activity in multiple
CNS nuclei contribute to the overall control of food intake,
energy expenditure, and body weight regulation. These results
have implications for the development of pharmacological
strategies in obesity research that would take advantage of the
putative synergistic relationship between LepR and GI satiation
signaling.EXPERIMENTAL PROCEDURES
Subjects and Materials
Adult male Sprague Dawley rats (300–350 g; Charles River) individually housed
in a room maintained at 23C with 12 hr:12 hr light/dark cycle (08:00 hr lights
on) had ad libitum access to chow (Purina Rodent Chow 5001) and water
except as noted. All procedures conformed to the institutional standards of
Animal Care and Use Committee (University of Pennsylvania).
The selective AMPK antagonist, compound C (Fisher Scientific), was chosen
to examine hindbrain AMPK-mediated effects on food intake (Hayes et al.,
2009; Kim et al., 2004). For the experiments addressing the interaction
between NTS LepR signaling and GI-derived satiation signals, CCK (CCK-8;
American Peptide, Inc.) was dissolved in sterile 0.9% saline and was adminis-
tered via i.p. injections (1.0 ml/kg).
Design and Construction of shRNA and Viral Production,
Purification, and Delivery
Hairpin RNA was designed to target specific regions of Lepr mRNA as
described (Hommel et al., 2006). Viral production was accomplished using a
triple-transfection, helper-free method and purified as described (Hommel
et al., 2003, 2006). The virus was purified via iodixanol gradients as described
(Hommel et al., 2006) and titered by infection of camptothecin-treated HT1080
cells.
Following 2 weeks of baseline behavioral and physiological testing, rats
were very lightly anesthetized via ketamine (9.0 mg/kg), xylazine (0.27 mg/kg),
and acepromazine (0.064 mg/kg). For bilateral mNTS/AP targeting, a total of
0.5 ml of purified virus (1–2 3 1011 infectious particles/ml) was delivered over
a 5 min period per hemisphere via a Hamilton syringe connected to an injectorell Metabolism 11, 77–83, January 6, 2010 ª2010 Elsevier Inc. 81
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guide cannula (Supplemental Experimental Procedures; 7.9 mm ventral to the
skull surface).
Tissue Collection
Ad libitum-fed rats were sacrificed by decapitation 1 hr into the light cycle.
Inguinal, retroperitoneal, epididymal, and perirenal WAT depots were removed
and weighed. Brains were rapidly removed, flash frozen in isopentane, and
stored at 80C until processing. Briefly, serial coronal sections (30 mm) of
the caudal brain stem were mounted on a slide and viewed immediately under
a fluorescent microscope (Nikon 80i) until EGFP-expressing neurons were
visualized. Next, under 43 magnification, micropunches of the AAV-shLepR/
shCtrl-infected mNTS/AP tissue were taken from two consecutive 80 mm
frozen coronal sections. Tissue collected from one section was kept frozen
for qPCR analysis of LepR and GAPDH, while tissue from the subsequent
section was kept frozen for immunoblot analysis of pAMPKa2 and total
AMPK. The next coronal section (30 mm) was again mounted on a slide to
confirm EGFP presence. This process continued until micropunches were
harvested for the entire mNTS/AP (at the AP level). Additionally, visualization
of infected neurons continued until the presence of EGFP-expressing neurons
was absent. Only data from rats with confirmed EGFP-expressing neurons in
the mNTS/AP were used in final statistical analysis.
Immunoblot Analysis
mNTS/AP tissue lysates from ad libitum-fed, chow-maintained rats (7 weeks
post-mNTS viral delivery) were prepared as described (Hayes et al., 2009;
Minokoshi et al., 2004). Briefly, tissue lysates of LepRKD (n = 5) and shCtrl
(n = 6) rats were transferred to PVDF membranes for immunoblot analysis.
pAMPKa-Thr 172 rabbit monoclonal antibody (pAMPKa2; Cell Signaling;
catalog number 2535S) was used to evaluate AMPK activity normalized to
immunoblot analysis of total AMPKa (reactive against a1 and a2 subunits;
Cell Signaling). Blots were quantified using NIH Image software.
RNA Isolation and Real-Time PCR
Total RNA was extracted from mNTS/AP tissue from ad libitum-fed, chow-
maintained rats (7 weeks post-mNTS viral delivery) using Trizol (Invitrogen),
and for further purification, the RNeasy kit (QIAGEN) was used. cDNA was
synthesized from 1 mg total RNA using High-Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems). qPCR was done in duplicate using TaqMan
Universal qPCR Master Mix (Applied Biosystems), and samples were run
using the Eppendorf Mastercycler ep realplex. The primer/probe sets for
LepR and GAPDH (internal control) were from Applied Biosystems (LEPR-
Rn00664624_m1; GAPD-435293 2E, respectively). Relative mRNA expression
was calculated using the comparative Ct method as described (Bence et al.,
2006).
Feeding Behavior
For 2 weeks prior to AAV delivery, daily body weight and food intake measure-
ments (±0.1 g) of rodent chow were made at 09:00 hr. In addition, rats (n = 9
shCtrl; n = 10 LepRKD) were trained to consume 15% (w/v) sucrose ad libitum
for 1 hr (09:30–10:30 hr) for 1 week prior to baseline testing. Briefly, water and
food were removed 20 min prior to testing. Five minutes prior to presentation
of a calibrated tube containing 15% sucrose solution, rats received counter-
balanced i.p. injections of CCK (3 mg/kg) or saline. Intakes were recorded
(±0.1 ml) at baseline and every 10 min for 60 min, after which chow and water
were returned. All injections were separated by a period of at least 48 hr.
Five days post-AAV delivery, behavioral testing of 15% sucrose intake
following i.p. CCK or saline continued for the duration of the experiment.
Five-and-a-half weeks post-AAV delivery, rats’ (n = 9 shCtrl; n = 10 LepRKD)
maintenance diet was switched to HF diet (Research Diets, D12492; 60%
Kcal from fat), and daily measurements continued for an additional 3 weeks.
In a separate group of rats (n = 6 shCtrl; n = 6 LepRKD) implanted with fourth
i.c.v. guide cannula (Supplemental Experimental Procedures), maintained
exclusively on chow, and housed in a reverse-light cycle (lights on, 22:00 hr),
additional food intake testing was conducted. Six weeks post-AAV delivery,
intake measurements of chow following counterbalanced i.p. CCK (3 mg/kg)
or saline delivery occurred as follows: 30 min predark cycle onset, food was
removed. Animals received i.p. injections at dark cycle onset, preweighed82 Cell Metabolism 11, 77–83, January 6, 2010 ª2010 Elsevier Inc.chow was returned 5 min later, and intakes were measured 30 min postfood
presentation. Data were analyzed as within-subject percent suppression of
30 min chow intake following CCK compared to intake following vehicle. At
3 weeks post-AAV delivery, rats underwent intake testing following counter-
balanced fourth i.c.v. delivery of the AMPK inhibitor compound C (15 mg;
dose subthreshold for effect in shCtrl rats from pilot studies) or DMSO (3 ml)
(Hayes et al., 2009). Briefly, 30 min predark cycle onset, food was removed.
Rats received fourth i.c.v. injections at dark cycle onset, and foodwas returned
15 min later. Feeding measurements occurred at 1, 3, 6, and 24 hr postfood
presentation. For both CCK and compound C testing, all injections were sepa-
rated by a minimum of 48 hr.
Data and Statistical Analyses
Data for each respective study were analyzed separately and expressed as
mean ± SEM. For all experiments, comparisons between treatment means
were analyzed by one- or two-way ANOVAs and, if appropriate, post hoc, pair-
wise comparisons were made using Tukey’s honestly significant difference
test with p < 0.05 considered statistically significant. Analyses were made
using PC-SAS (version 8.02, SAS Institute) mixed procedure.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental Results, two figures, and Supplemental References and can
be found with this article online at doi:10.1016/j.cmet.2009.10.009.
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